London · Delayed Price · Currency is GBP · Price in GBX Judges Scientific Earnings Call Transcripts
Fiscal Year 2025
-
FY2025 saw revenue growth but flat profits due to U.S. funding cuts and weak order intake, partially offset by strong performance in industrial and Asian markets. Cash generation remained robust, dividend increased 10%, and guidance for 2026 EPS is 200–250p, with long-term fundamentals intact.
-
Revenue and profit grew strongly year-over-year, driven by Geotech and China, but U.S. funding cuts and weak order intake tempered results. Cash generation remains robust, leverage is down, and dividends continue to rise. Management expects to meet revised guidance and remains confident in long-term growth drivers.
Fiscal Year 2024
-
2024 saw a 2% revenue decline and a 24% drop in adjusted EPS due to weak order intake, especially from China and the absence of a major coring contract. Despite this, three acquisitions were completed, cash conversion was strong, and the dividend was raised 10%.
-
H1 2024 saw a 1% revenue decline and 13% drop in adjusted operating profit amid subdued order intake, especially in China, and absence of a major contract. Despite short-term headwinds, the group completed three acquisitions, raised its dividend 10%, and extended banking facilities.